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Summary
a 44-year-old Caucasian man with a history of deceased 
donor renal transplant for end-stage renal disease from 
alport’s syndrome (as), presented with a spontaneous 
subarachnoid haemorrhage and hydrocephalus. 
Following an external ventricular drain for the 
hydrocephalus, a Ct angiography revealed a dissection 
of the left vertebral artery extending into vertebro-basilar 
junction necessitating a bypass between left occipital 
artery to left posterior inferior cerebellar artery. He had a 
posterior fossa Craniectomy, C1 laminectomy and coiling 
off, of the left vertebral artery. postprocedure course was 
prolonged but uneventful with complete recovery and 
normal renal function 18 months postpresentation. as, 
a disease caused by abnormalities in the synthesis of 
type IV collagen, can cause aneurysms with severe and 
permanent neurological sequalae. We present a case of 
as with intracranial arterial dissection with potential life-
threatening consequences and discuss the genetic and 
molecular basis of as along with review of the relevant 
literature.
BaCkground
Alport’s syndrome (AS) is a rare genetic disorder 
and typically presents with nephropathy secondary 
to progressive glomerulonephritis, high tone senso-
rineural deafness and ocular abnormalities (ante-
rior lenticonus, peri macular flecks, spontaneous 
capsular rupture).
The pathophysiology in AS is explained by muta-
tions in the genes encoding alpha-3 (IV), alpha-4 
(IV), or alpha-5 (IV) chains of type IV collagen 
found in the basement membranes. Collagen forms 
the main building blocks of the arterial walls, and 
there is a strong molecular basis behind occurrence 
of major arterial aneurysm in disorders of collagen 
synthesis. However, presentation of patients with 
AS with intracranial aneurysms is minimally studied 
and reported.
This case highlights the need for awareness of this 
rare, but potentially life-threatening complication 
in patients with AS. Large-scale evaluation of the 
surgical and autopsy specimens of vascular aneu-
rysms in patients with collagenopathy is needed to 
establish the relation better. Also, future clinical and 
epidemiological studies are warranted to empha-
sise stronger and well-defined association between 
vascular and intracranial aneurysms in patients with 
collagen synthesis dysfunction such as in AS.
CaSe preSenTaTion
A 44-year-old Caucasian man transferred to 
the neurosurgical unit following a spontaneous 
subarachnoid haemorrhage with hydrocephalus. He 
initially presented to a local hospital with a 24-hour 
history of sudden, severe headache with associ-
ated nausea and vomiting. On arrival, his Glasgow 
Coma Scale (GCS) was 15/15. Following multiple 
episodes of intravenous morphine for pain, he 
went into respiratory distress requiring ventilatory 
Figure 1 CT Angiogram with a dissection in the 
intradural segment of the left vertebral artery.
Figure 2 Left occipital artery to posterior inferior 
cerebellar artery bypass.
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support. Subsequently, he transferred to our facility for higher 
level of care.
Patient’s prior medical history included end-stage renal disease 
(ESRD) from AS, 20 years ago. He was on haemodialysis for 
8 years, subsequently received a diseased donor renal transplant 
and was on Tacrolimus and Mycophenolate for immunosuppres-
sion. His other past medical history included, non-hodgkin’s 
lymphoma treated with chemo and radiation and in remission. 
He was also on aspirin, furosemide, ranitidine, senna, atenolol, 
calcium supplements and paracetamol. He was a non-smoker, 
and his maternal uncle had ESRD from AS.
Soon after his admission to the neurosurgical unit, he received 
an external ventricular drain for the hydrocephalus. Laboratory 
work-up revealed, stable serum creatinine at his baseline, normal 
blood urea nitrogen, electrolytes, complete blood count and 
urinalysis. A CT angiography (CTA) revealed a dissection in the 
intradural segment of the left vertebral artery (figure 1), which 
continued distally beyond the origin of the left posterior inferior 
cerebellar artery (PICA) on to the vertebro-basilar junction.
inveSTigaTionS
CTA of the brain.
diFFerenTial diagnoSiS
Acute ischaemic or haemorrhagic cerebrovascular accident.
TreaTmenT
He underwent left occipital artery to PICA bypass (figure 2) 
along with a standard posterior fossa craniectomy with C1 
laminectomy. Postbypass the left vertebral artery was coiled off 
(figure 3). The occipital artery and PICA bypass was patent. 
The angiogram for the procedure, however, revealed a dissec-
tion of the right vertebral as well with possible involvement of 
the basilar artery. Given the high possibility of causing infarc-
tion with further intervention on the only remaining verte-
bral vessel, decided to treat conservatively. His post procedure 
imaging revealed possible area of ischaemia in the brain stem 
and the cerebellum (PICA territory). He had a prolonged period 
of recovery in the neuro intensive care unit and recovered to a 
GCS of 14/15 (E4V4M6). A programmable ventriculo-perito-
neal shunt was inserted and discharged to the local neuro reha-
bilitation unit in a stable condition.
ouTCome and Follow-up
Eighteen months following his presentation, he remained 
symptom free with complete recovery, and his renal function 
remained at baseline.
diSCuSSion
In 1927, an English Physician, Cecil A Alport described members 
of three generations in a family, with combinations of progres-
sive hereditary nephritis and hearing impairment.1 Subsequently, 
many more families were described with similar characteristics, 
and the eponymous title, ‘Alport’s syndrome’ was coined in 
1961.2 Though incidence is unknown, AS has been implicated 
in renal replacement therapy for ESRD in 1.5% of children in 
Europe.3 Data from the USA demonstrates that AS accounts for 
3% of children with ESRD and 0.2% of adults with ESRD.4
molecular biology and genetics of aS
AS is genetically heterogeneous, and it results from mutations in 
one of the three subunits of a type IV collagen subunits (alpha 
chains), that makes a type IV collagen molecule, which forms a 
significant component of the basement membranes. The three 
sub units of the type IV collagen molecule, the alpha (IV) chains, 
are intertwined into a triple helical structure. Two molecules 
interact at the C-terminal end, and four molecules communi-
cate at the N-terminal end to form a ‘chicken wire’ network. 
Alpha (IV) chains have six isomers and are designated as alpha-1 
to alpha-6. Normal glomerular basement membrane (GBM) 
contains two collagen networks, the first consisting of the 
alpha-1 (IV)/alpha-2 (IV) chains and the second of the alpha-3 
(IV)/alpha-4 (IV)/alpha-5 (IV) chains.5 In, table 1, details of the 
various tissue distributions of Alpha (IV) chains of collagen are 
included.
Overall, the primary micro-structural abnormality in patients 
with AS results from abnormalities of basement membrane 
expression of alpha-3 (IV), alpha-4 (IV), and alpha-5 (IV) chains 
of type IV collagen. In the basement membrane of a patient with 
AS, these chains are either under expressed or absent. A spec-
trum of mutations in type IV collagen genes can lead to expres-
sion of different phenotypes and give rise to variable clinical 
presentations. Table 2 depicts the mutation of the genes coding 
for alpha chains of type IV collagen in AS.
There are three genetic forms of AS that are recognised:
a. X-linked: The most common form (85%) that results from 
mutations in the encoding of the alpha-5 (IV) chain of type 
IV collagen.
b. Autosomal recessive: Caused by mutations in genes encoding 
either alpha-3 (IV) or alpha-4 (IV) chains and is responsible 
for approximately 10%–15% of cases.
c. Autosomal dominant: Rare form that is caused by mutations 
in genes encoding either alpha-3 (IV) or alpha-4 (IV) chains.
pathogenesis of aneurysms in aS
Our literature search for the reported cases of vascular aneu-
rysms in AS (keywords: ‘Alport’s,’ ‘Aneurysm’) revealed only 
three reports,6–8 and did not yield reports with vertebro-basilar 
artery aneurysms. The index patient has history of AS and had 
a deceased donor renal transplant for ESRD. He denied prior 
cerebro-vascular symptoms and hence did not receive vascular 
screening or angiogram before the presentation. Given the 
pathogenesis, we postulate that the genetic defect leading to 
abnormality in type IV collagen molecule may have resulted in 
the formation of the aneurysm in our patient with AS.
Figure 3 Left vertebral artery coiled off.
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Yong-Zhong and van Alphen reviewed the major theories on 
the formation and growth of saccular aneurysms.9 Disruption 
of the internal elastic lamina is thought to be an critical require-
ment for the creation of saccular aneurysms, because it provides 
most of the strength to the cerebral arteries.9 Degeneration of this 
layer is a persistent feature of all saccular aneurysms. A coexisting 
medial defect and haemodynamic stress at an apex may aggravate 
degeneration at that point.10 11 Hypertension does not seem to be a 
significant originating factor in some aneurysm patients, but it may 
facilitate the formation and growth of saccular aneurysms,.11
Incidence of intracranial aneurysm in the children and young 
people may represent a distinct pathophysiological entity from 
adults.12 Cerebral, aneurysms in this age group fail to support 
a degenerative or chronic haemodynamic pathogenetic origin. 
Therefore, molecular and genetic aspect of ethology may have 
greater importance. Childhood intracranial aneurysms are rela-
tively rare, and has been reported to have male predominance, 
predilection for posterior circulation and carotid bifurcation 
along with a propensity to reach larger sizes.13 14 Arterial defi-
ciency of reticular fibres is of importance in the development 
and rupture of saccular aneurysm in childhood.15 We should, 
however, note that formation of premature vascular aneurysms 
and fragile nature of cerebral arteries commonly associated with 
type III collagen mutations.16 17
Specific connective tissue disorders such as Ehlers-Danlos 
syndrome, Marfan’s syndrome, osteogenesis imperfecta, pseudox-
anthoma elasticum, neurofibromatosis type I and polycystic kidney 
disease, have been studied for their increased vascular fragility.18–20 
Genetically defective form of type III collagen is believed to be a 
critical element in both vessel enlargement and aneurysmal rupture 
in these disorders.21 Fibromuscular dysplasia (FMD) is a multifocal, 
noninflammatory, nonatherosclerotic arteriopathy of uncertain aeti-
ology, most commonly affecting segments of small to medium-sized 
arteries. Pathophysiological similarities between FMD and AS may 
be unclear, but there may be a common mechanism of pathogenesis 
in both syndromes, related to the expression of type IV collagen in 
the vascular basal membranes.22 23
Collagen Type IV and type V are localised to the endothe-
lial basement membrane and basement membranes of smooth 
muscle cells of the intima and media.24 Type IV collagen plays a 
fundamental and vital role in vessel wall integrity, and it closely 
influences and interacts with various factors related to angio-
genic activity.25 Skirgaudas et al studied expression and distri-
bution of angiogenesis growth factors and selected vascular wall 
matrix proteins (fibronectin, Type IV collagen and alpha smooth 
muscle actin) in the walls of human intracranial aneurysms from 
surgical/autopsy specimen.26 Expression of matrix proteins on 
the aneurysmal vessel wall was found to be diffuse and disor-
ganised as compared with their organisation in control vessels. 
A possible biological response related to the angiogenesis factors 
was noted as evident by strong patchy expression of vascular 
endothelial growth factors within the aneurysmal walls. Thus, 
abnormal or inadequate synthesis of type IV collagen subunits 
may possess a significant role in this pathological process.26
Our report raises the concern of vascular aneurysms in AS and 
stimulates the idea that it may be reasonable and advisable to 
look for collagenopathies in young patients with vascular aneu-
rysms. ICA may be commoner in the population of collagenopa-
thies than previously suspected and non-invasive screening may 
be appropriate. Little has been done to assess the risk of severe 
arterial aneurysms in AS and possible benefit of a screening 
protocol for eligible patients. Non-invasive low risk neuroim-
aging studies such as MR angiography (MRA) or CTA may prove 
to be useful screening modalities in selected cases. Large scale 
evaluation of surgical and autopsy specimens of vascular aneu-
rysms from patients with known collagenopathy is needed to 
demonstrate more unambiguous molecular and genetic correla-
tion of vascular aneurysms and collagen abnormalities. Further 
clinical and epidemiological studies are warranted to estab-
lish stronger and well-defined association between prevalence 
of intracranial and other vascular aneurysms in patients with 
collagen synthesis dysfunction such as in AS.
Table 1 Tissue distribution of alpha chains of type IV chains of 
collagen
Type of alpha (iv) chains distribution in tissues
Alpha-1 All tissues (Ubiquitous)
Alpha-2 All tissues (Ubiquitous)
Alpha-3 Kidney (GBM, distal TBM), Eye (Descemet membrane, 
Bruch membrane, anterior lens capsule), Lungs, Ear 
(cochlea)
Alpha-4 Kidney (GBM, distal TBM), Eye (Descemet membrane, 
Bruch membrane, anterior lens capsule), Lungs, Ear 
(cochlea)
Alpha-5 Kidney (GBM, distal TBM), Eye (Descemet membrane, 
Bruch membrane, anterior lens capsule), Lungs, Ear 
(cochlea)
Alpha-6 Kidney (Distal TBM), Skin (epidermal basement 
membrane)
GBM, glomerular basement membrane; TBM, tubular basement membrane.
Table 2 Mutations of the genes coding for alpha chains of type IV 
collagen in AS
Type of alpha 
(IV) chain
Genes Location on the 
chromosome
Relevant mutation found in
Alpha-1 COL4A1 13 Not known
Alpha-2 COL4A2 13 Not known
Alpha-3 COL4A3 2q36-q37 ARAS*
Alpha-4 COL4A4 2q36-q37 ARAS
Alpha-5 COL4A5 Xq22.3 XLAS†
Alpha-6 COL4A6 X Leiomyomatosis‡
*Autosomal recessive AS (mutations spanning 5’ regions of COL4A5 and COL4A6 genes).
†X-linked AS: to date, more than 300 mutations of all types have been described in the 
COL4A5 gene.
‡Found in autosomal recessive AS.
AS, Alport’s syndrome.
learning points
 ► Alport’s syndrome (AS) is a rare genetic disorder and 
typically presents with nephropathy from progressive 
glomerulonephritis, high tone sensorineural deafness, and 
ocular abnormalities.
 ► AS is genetically heterogeneous, and results from mutations 
in one of the three subunits of a type IV collagen alpha 
chains, that makes a type IV collagen molecule.
 ► Though rarely reported, vascular aneurysms may be 
commoner in the population of collagenopathies than 
previously suspected and non-invasive screening may be 
appropriate.
 ► More extensive clinical and epidemiological studies 
are warranted to establish stronger and well-defined 
association between vascular aneurysms in patients with 
collagenopathies.
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